Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.

Oldenburg, Catherine E; Doan, Thuy

Oldenburg, Catherine E; Doan, Thuy.

Oldenburg CE; Department of Ophthalmology, University of California, San Francisco, San Francisco, California.
Doan T; Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California.

Am J Trop Med Hyg ; 102(6): 1154-1155, 2020 06.

Article in English | MEDLINE | ID: covidwho-601051

Subject(s)

Antiviral Agents/therapeutic use; Betacoronavirus/pathogenicity; Coronavirus Infections/drug therapy; Pandemics; Pneumonia, Viral/drug therapy; Randomized Controlled Trials as Topic/standards; Azithromycin/therapeutic use; Betacoronavirus/drug effects; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques/standards; Coronavirus Infections/diagnosis; Coronavirus Infections/epidemiology; Drug Repositioning; Humans; Hydroxychloroquine/therapeutic use; Lopinavir/therapeutic use; Pneumonia, Viral/diagnosis; Pneumonia, Viral/epidemiology; Practice Guidelines as Topic; Ritonavir/therapeutic use; SARS-CoV-2; Sample Size; United States/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Randomized Controlled Trials as Topic / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: North America Language: English Journal: Am J Trop Med Hyg Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google